ASAdam J. Spanier

Adam J. Spanier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam J. Spanier has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bruce P. Lanphear

    Cincinnati Children’s Environmental Health Center, Cincinnati Children’s Hospital Medical Center

    3 shared publications
  • Michelle B. Lierl

    Division of Allergy and Clinical Immunology, Cincinnati Children’s Hospital Medical Center

    2 shared publications
  • Richard W. Hornung

    Cincinnati Children’s Environmental Health Center, Cincinnati Children’s Hospital Medical Center

    2 shared publications
  • Robert S. Kahn

    Division of General & Community Pediatrics, Cincinnati Children’s Hospital Medical Center

    2 shared publications
  • Guangyun Sun

    Department of Environmental Health, College of Medicine, University of Cincinnati

    1 shared publication
  • Michelle Lierl

    From Cincinnati Children’s Environmental Health Center, Division of General and Community Pediatrics, and the Division of Allergy and Clinical Immunology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio

    1 shared publication

Latest Publications

  • Environmental exposures, nitric oxide synthase genes, and exhaled nitric oxide in asthmatic children

    by Adam J. Spanier, Robert S. Kahn, Richard W. Hornung, Ning Wang, Guangyun Sun, Michelle B. Lierl, Bruce P. Lanphear

    Exhaled nitric oxide (FeNO), a measure of airway inflammation, is being explored as a tool to guide asthma management in children. Investigators have identified associations of genetic polymorphisms in nitric oxide synthase genes (NOS1 and NOS3) with FeNO levels; however, none have explored whether these polymorphisms modify the relationship of environmental exposures with FeNO. The objective of this project was to evaluate the association of NOS polymorphisms and environmental exposures with FeNO levels among children with asthma. We conducted a 12‐month prospective cohort study of 225 tobacco‐smoke exposed children (6–12 years) with doctor‐diagnosed asthma. We assessed environmental exposures (tobacco, indoor allergens, & airborne particulates), polymorphisms in NOS1 (an intronic AAT tandem repeat) and NOS3 (G894T), and FeNO levels. There was no association of NOS1 or NOS3 polymorphisms with FeNO levels. There were no significant interactions of environmental exposures and the NOS1 polymorphism with FeNO levels. In contrast, there was an interaction of the NOS3 polymorphism and airborne nicotine concentration with FeNO levels (P = 0.01). Among GG genotype individuals, nicotine exposure did not affect FeNO levels; however, among individuals with at least one T allele, higher nicotine exposure was associated with lower FeNO levels (approximately 5 ppb decrease from the lowest to the highest quartile). We conclude that genetic differences may explain some of the conflicting results in studies of the effects of tobacco smoke exposure on FeNO levels and may make FeNO interpretation difficult for a subset of children with asthma. Pediatr Pulmonol. 2009; 44:812–819.


  • Seasonal variation and environmental predictors of exhaled nitric oxide in children with asthma

    by Adam J. Spanier, Richard W. Hornung, Robert S. Kahn, Michelle B. Lierl, Bruce P. Lanphear

    The fraction of exhaled nitric oxide (FeNO), a measure of airway inflammation, shows promise as a noninvasive tool to guide asthma management, but there is a paucity of longitudinal data about seasonal variation and environmental predictors of FeNO in children. The objective of this project was to evaluate how environmental factors affect FeNO concentrations over a 12‐month study period among children with doctor diagnosed asthma. We conducted a prospective cohort study of 225 tobacco‐smoke exposed children age 6–12 years with doctor‐diagnosed asthma including measures of FeNO, medication use, settled indoor allergens (dust mite, cat, dog, and cockroach), and tobacco smoke exposure. Baseline geometric mean FeNO was 12.4 ppb (range 1.9–60.9 ppb). In multivariable analyses, higher baseline FeNO levels, atopy, and fall season were associated with increased FeNO levels, measured 6 and 12 months after study initiation, whereas inhaled steroid use, summer season, and increasing nicotine exposure were associated with lower FeNO levels. In secondary analyses of allergen sensitization, only sensitization to dust mite and cat were associated with increased FeNO levels. Our data demonstrate that FeNO levels over a year long period reflected baseline FeNO levels, allergen sensitization, season, and inhaled steroid use in children with asthma. These results indicate that FeNO levels are responsive to common environmental triggers as well as therapy for asthma in children. Clinicians and researchers may need to consider an individual's baseline FeNO levels to manage children with asthma. Pediatr Pulmonol. 2008; 43:576–583.


  • Environmental exposures and exhaled nitric oxide in children with asthma

    by Adam J. Spanier, Richard Hornung, Michelle Lierl, Bruce P. Lanphear